A bioelectronic solution for people with migraine and cluster headache | Salvia BioElectronics
Overview
Salvia BioElectronics is a company focused on neuromodulation therapy for chronic migraine, headquartered in Eindhoven, North Brabant. The company develops MySalvia Therapy, which features ultra-thin implants that target key nerves involved in migraine and can be activated using a wearable device. This therapy is designed for everyday use and is currently undergoing evaluation in clinical studies. Founded in 2017, Salvia BioElectronics combines expertise from device makers and MedTech entrepreneurs experienced in medical devices and neuromodulation. The company operates in the United States, Europe, and Australia, advancing its clinical development with support from leading investors. Salvia is also investigating the potential of its technology for treating cluster headaches.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Eindhoven, North Brabant
- Type
- Privately Held
- Founded
- 2017
- Followers
- 7,731
- Specialties
- bioelectronics, neurostimulation, medical devices, start-ups, entrepreneurship, R&D, business development, and neurotechnology
- Locations
- High Tech Campus 37 Eindhoven, North Brabant 5656 AE, NL
Funding
Total rounds: 6
Last round: Series B, Jun 27, 2025
Last round amount: US$ 60.4M